Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Integrum ABOSTO:INTEG B -2.45%53 Days Payable is 68.38 as of Apr. 2026, which is 70% below its 10-year median of 227.11. GuruFocus rates OSTO:INTEG B with a GF Score™ of 53/100 and a GF Value™ of kr17.75 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 794 Medical Devices & Instruments companies, Integrum AB ranks better than 61.59% on this metric.
Integrum AB's average Accounts Payable for the
three
months ended in Apr. 2026 was kr7.23 Mil. Integrum AB's Cost of Goods Sold for the
three
months ended in Apr. 2026 was kr9.65 Mil.
Hence, Integrum AB's Days Payable for the
three
months ended in Apr. 2026 was 68.38.
The historical rank and industry rank for Integrum AB's Days Payable or its related term are showing as below:
OSTO:INTEG B'
s Days Payable Range Over the Past 10 Years
Min: 91.56 Med: 227.11 Max: 303.1
Current: 91.56
During the past 12 years, Integrum AB's highest Days Payable was 303.10. The lowest was 91.56. And the median was 227.11.
OSTO:INTEG B's Days Payable is ranked better than 61.59% of 794
companies
in the Medical Devices & Instruments industry
Industry Median: 67.97
vs OSTO:INTEG B: 91.56
Integrum AB's Days Payable
declined
from Apr. 2025 (71.31) to Apr. 2026 (68.38).
It may suggest that Integrum ABaccelerated paying its suppliers.
Integrum AB Days Payable Related Terms
Integrum AB Days Payable Historical Data
* Premium members only.
The historical data trend for Integrum AB's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSTO:INTEG B vs ABT, SYK, MDT: Days Payable Comparison
For the Medical Devices subindustry, Integrum AB's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Integrum AB Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Integrum AB's Days Payable distribution charts can be found below:
* The bar in red indicates where Integrum AB's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Integrum AB's Days Payable for the fiscal year that ended in Apr. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Integrum AB (OSTO:INTEG B) has a Days Payable of 68.38 as of Apr. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Integrum AB and its competitors. This is 70% below median its historical median of 227.11. Over the past decade, Integrum AB's Days Payable has ranged from 91.56 to 303.10. According to the industry distribution chart, Integrum AB ranks #305 out of 794 companies in the Medical Devices & Instruments industry, placing it in the top 38.4%.
Is Integrum AB's Days Payable too high?
Integrum AB's current Days Payable of 68.38 is 70% below median its 10-year median of 227.11. Over the past 10 years, this metric has ranged from a low of 91.56 to a high of 303.10. The Medical Devices & Instruments industry median Days Payable is 67.97. Integrum AB's value of 68.38 is 0.6% above this industry median. Based on the distribution chart, Integrum AB ranks #305 out of 794 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Integrum AB has a GF Score™ of 53/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Integrum AB's Days Payable compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Integrum AB ranks #305 out of 794 companies for Days Payable. This puts Integrum AB in the upper half of its industry. The industry median Days Payable is 67.97. Integrum AB's value of 68.38 is 0.6% above this benchmark. Historically, Integrum AB's own Days Payable has ranged from 91.56 to 303.10 over the past decade. While the company's 10-year median is 227.11 vs. the industry median of 67.97, Integrum AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 67.97, based on 794 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Integrum AB's current Days Payable of 68.38 is 0.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Integrum AB and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 67.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Integrum AB's current Days Payable is 68.38, which is 70% below median its own 10-year median of 227.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Integrum AB stock overvalued right now?
Based on GuruFocus' analysis, Integrum AB (OSTO:INTEG B) is currently considered Possible Value Trap. The stock's GF Value™ is kr17.75, compared to a current price of kr7.96 — trading 55.2% below its estimated fair value. The current Days Payable is 68.38, which is 70% below median its 10-year median of 227.11 and 0.6% above the Medical Devices & Instruments industry median of 67.97. Integrum AB's overall GF Score™ is 53/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Integrum AB (OSTO:INTEG B), the current Days Payable is 68.38 as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Integrum AB (OSTO:INTEG B) Overvalued in 2026?
Based on GuruFocus' analysis, Integrum AB stock appears to be undervalued.
The current stock price of kr7.96 is trading 55.2% below its estimated GF Value™ of kr17.75.
GuruFocus considers Integrum AB to be Possible Value Trap.
Key valuation signals for OSTO:INTEG B:
Days Payable: 68.38 (70% below median its 10-year median of 227.11)
GF Value™: kr17.75 vs. price of kr7.96 (55.2% below fair value)
Industry Position: 0.6% above the Medical Devices & Instruments median (#305 of 794)
No single metric tells the full story. See the OSTO:INTEG B stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Integrum AB provides the system for bone-anchored prostheses that improves the lives of people with amputations. Its solutions include OPRA implant system, Neural prosthetics, Phantom limb pain treatment, and Prosthetic components. The company is also engaged in developing technology for mind-controlled prostheses and treatment for phantom limb pain.
53GF Score
Get the complete analysis for OSTO:INTEG B
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:INTEG B has been successfully added to your 
